BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20191001T093000
DTEND;TZID=Europe/London:20191001T163000
DTSTAMP:20260410T140851
CREATED:20190806T073521Z
LAST-MODIFIED:20190806T073521Z
UID:18006-1569922200-1569947400@staging.medilinkmidlands.com
SUMMARY:MPD Training Course: Strategic Implementation of European In Vitro Diagnostic Regulations
DESCRIPTION:Legal Manufacturers of In Vitro Diagnostic products need to be aware of the scope and implications of the new European In Vitro Diagnostics Regulations 2017/746. Organisations must be realistic and prepared. Not only for the impact of changes in the short-term\, but for the long-term implications to the development and maintenance of diagnostic products in the European Market. We only have until May 2022 to complete this compliance journey for some products\, so it is strategically critical that all impacted businesses have fully understood and assessed the impacts on their business. \nMedilink WM\, in conjunction with Acclaim Biomedical Consulting Ltd. is offering a one day workshop to focus on the implementation of European In Vitro Diagnostics Regulations. This will provide attendees with detailed understanding of strategic impacts and possible solutions which may be used to ensure compliance going forwards. \nWhy attend? \nBy attending this workshop you will: \nGain a thorough understanding of the changes and strategic consideration of the major impact areas of the revised regulations with indepth review of the major clauses of the regulation.\nHave the confidence and knowledge to review your own business and formulate plans to meet the transition to the IVDR based on this one day event\nGain insight and tools to plan and implement into your business strategy for continued access to the European market\, by the deadlines set in the new regulations\nLearn from other like minded business leaders\, on their challenges and strategies to achieve the necessary legal process.\nMeet the expert: \nManaging Director Richard Young has an extensive background in regulatory affairs in addition to GMP (quality assurance)\, GLP (laboratory testing) and GCP (clinical). Spanning over two decades\, these core skill areas have been developed with experience in products ranging from class 3 devices such as Orthopaedic implants (IIb) neurological robots\, through electromedical devices such as infusion systems and cardio vascular products. Richard brings a blend of pragmatism and experience to these disciplines that facilitates insightful problem solving approaches as well as solid solutions. \nRichard’s skills and experience includes such areas as the development and implementation of effective quality management systems\, auditing to ISO and FDA QSIT standards\, and operating at national and international level through industry associations including Eucomed\, ABHI and ABHI Technical Policy Group. \nTarget audience \nDesigned for business leaders with executive responsibilities as well as Quality Assurance and Regulatory Professionals. \nThis course quickly identifies the areas of strategic impact\, possible costs and the time lines associated with the new EU In Vitro Diagnostic Device Regulations. \nBooking information: \nDelegate Fee: \nEarly bird fee – Register your place before Friday 23 August and receive a 10% discount \nMember fee: £180+VAT \nNon-Member fee: £215+VAT \nTo secure your place please contact Zoe Heather at zoeh@medilinkwm.co.uk or call 0121 452 5630 \nInvoices will be sent once booking has been confirmed by Medilink WM.
URL:https://staging.medilinkmidlands.com/event/mpd-training-course-strategic-implementation-of-european-in-vitro-diagnostic-regulations/
LOCATION:MTIC\, 4 Greenfield Crescent\, Edgbaston\, B15 3BE
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
END:VCALENDAR